Please use a PC Browser to access Register-Tadawul
ConnectM Reaffirms $62M Increased Implied Equity Value With Buy-Out Group
Contineum Therapeutics, INC. CNTM |
|
As announced on April 3, 2025, the buy-out offer contemplates the acquisition of all outstanding shares of ConnectM at a cash price of $1.60 per share. At the time of the offer, the Buy-Out Group had referenced the Company's shares outstanding as of December 31, 2024, which implied an equity value of approximately $46.5M. ConnectM has since informed the Buy-Out Group that its current shares outstanding total 38,760,828, implying a total equity value of approximately $62.02 million. Upon receiving this information, the Buy-Out Group confirmed its intention to proceed with the $1.60 per share price for the remaining issued and outstanding publicly held common shares of ConnectM.